Paper Details
- Home
- Paper Details
Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Author: , BarbarashR A, BergJ E, GunnillL B, JonesT M, JorizzoJ L, KatzD H, KhalilM H, MikolichD J, MorrowP R, PopeL E, RuoffG E, SacksS L, ThistedR A, YakatanG J
Original Abstract of the Article :
BACKGROUND: Recurrent herpes simplex labialis (HSL) occurs in 20% to 40% of the US population. Although the disease is self-limiting in persons with a healthy immune response, patients seek treatment because of the discomfort and visibility of a recurrent lesion. OBJECTIVE: Our purpose was to deter...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1067/mjd.2001.116215
データ提供:米国国立医学図書館(NLM)
A Balm for the Blisters: Docosanol 10% Cream for Herpes Simplex Labialis
Herpes simplex labialis (HSL), commonly known as cold sores, is a viral infection that can cause painful and unsightly blisters on the lips. This study investigates the effectiveness of topical docosanol 10% cream in treating episodes of acute HSL. The researchers conducted two identical double-blind, placebo-controlled trials to compare the efficacy of docosanol with a placebo.
A Promising Treatment: Docosanol's Effectiveness
The study found that docosanol 10% cream significantly reduced the time to healing for HSL episodes compared with the placebo. It also demonstrated a faster reduction in pain and other symptoms, including itching, burning, and tingling.
A New Frontier in Treatment: Docosanol's Potential
This study highlights the potential of docosanol 10% cream as an effective treatment for HSL, offering a safe and well-tolerated alternative to existing therapies. It encourages further research to explore its role in managing recurrent HSL and to investigate its long-term efficacy and safety.
Dr. Camel's Conclusion
This study, like a camel caravan discovering a refreshing oasis in the desert, provides evidence of the effectiveness of docosanol 10% cream in treating herpes simplex labialis. It offers a promising treatment option for those seeking relief from this common and often bothersome condition. The research encourages continued investigation into the use of docosanol for HSL and its potential to improve patient outcomes.
Date :
- Date Completed 2001-08-23
- Date Revised 2014-11-20
Further Info :
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.